<DOC>
	<DOCNO>NCT00191464</DOCNO>
	<brief_summary>The primary objective study show prandial insulin regimen , consist premeal insulin lispro `` mid mixture '' ( combine regimen insulin lispro `` mid mixture '' insulin lispro `` low mixture '' ) plus metformin result significantly well overall glycemic control ( low HbA1c ) endpoint once-daily insulin glargine plus metformin . Insulin lispro `` mid mixture '' consist 50 % insulin lispro 50 % NPL . Insulin lispro `` low mixture '' consist 25 % insulin lispro 75 % NPL . In substudy approximately 60 patient , additional data collect marker associate risk atherosclerosis cardiovascular disease context control , outpatient , high-fat test meal .</brief_summary>
	<brief_title>Long-Term Effects Insulin Plus Metformin Regimens Overall Postprandial Glycemic Control Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Have type 2 diabetes ( World Health Organization [ WHO ] classification Have use one follow oral antihyperglycemic medicationsmetformin secondgeneration sulfonylurea ( example , glibenclamide , glyburide , glipizide , gliclazide , glimepiride ) alone combination one two insulin injection per day least 3 month immediately prior enter study . Patients use 2 insulin injection per day subcutaneous insulin infusion prior study eligible participate . Have hemoglobin A1c 6.5 % 11 % , inclusive , accord central laboratory Visit 1 . Have clinically acceptable LDLC , investigator 's opinion , Visit 1 . As determined investigator , capable willing learn use insulin injection pen ; comply prescribed diet , exercise , medication regimen ; perform selfmonitoring blood glucose ; use patient diary require protocol . Have hypersensitivity metformin know allergy metformin hydrochloride , insulin lispro MM , insulin lispro LM , insulin glargine , excipients contain product . Have know metabolic lactic acidosis . Have history renal transplantation currently receive renal dialysis serum creatinine great equal 135 micromol/L ( 1.5 mg/dL ) males great equal 110 micromol/L ( 1.2 mg/dL ) female . Have cardiac disease functional status Class III IV Have obvious clinical sign symptom liver disease , acute chronic hepatitis , alanine transaminase ( ALT ) great three time upper limit reference range define central laboratory .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>